InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Dreyfus Andrew, Director. Director active across 1 companies, notably Ironwood Pharmaceuticals INC. In total, 9 filings have been published. The latest transaction was filed on 1 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
021,571 shares0
Class A Common Stock
SEC:0001209191-22-033965:0·
01,431 shares0
Class A Common Stock
SEC:0001209191-21-070234·
01,431 shares0
Class A Common Stock
SEC:0001209191-21-070234:0·
01,344 shares0
Class A Common Stock
SEC:0001209191-21-056656·
01,344 shares0
Class A Common Stock
SEC:0001209191-21-056656:0·
01,453 shares0
Class A Common Stock
SEC:0001209191-21-040921·
01,453 shares0
Class A Common Stock
SEC:0001209191-21-040921:0·
022,766 shares0
Class A Common Stock
SEC:0001209191-21-038191·
022,766 shares0
Class A Common Stock
SEC:0001209191-21-038191:0·
9 of 9 declarations
About Dreyfus Andrew
Andrew Dreyfus is a Board Member at Ironwood Pharmaceuticals Inc. He brings valuable expertise to the board, contributing to the company's strategy and governance. His experience in the pharmaceutical sector allows him to provide unique insights into market challenges and growth opportunities. His role is essential in guiding Ironwood towards a prosperous future.
